Molecular docking is a computational technique used in drug discovery and molecular biology to predict the interaction between small molecules, typically drugs, and target proteins. It plays a crucial role in rational drug design by estimating the binding affinity and orientation of ligands within the active site of a protein receptor. At its core, molecular docking involves the simulation of the physical interaction between the ligand and receptor molecules to identify potential binding poses and determine the strength of the interaction.
The process begins with the preparation of both the ligand and receptor structures, including the removal of water molecules and optimization of hydrogen bonding. Next, algorithms such as Lamarckian genetic algorithm (LGA), simulated annealing, or Monte Carlo-based methods are employed to explore the conformational space of the ligand and receptor and find energetically favorable binding modes. These algorithms often utilize scoring functions to evaluate the fitness of each docking pose based on factors such as electrostatic interactions, van der Waals forces, and hydrogen bonding patterns. Molecular docking can be classified into two main approaches: ligand-based docking, which relies on the structural information of the ligand alone, and protein-ligand docking, which considers both the ligand and receptor structures.
Protein-ligand docking is more widely used and involves the prediction of binding poses by systematically sampling the spatial orientations and conformations of the ligand within the binding pocket of the protein. Various software tools and algorithms have been developed for molecular docking, including AutoDock, DOCK, and Glide, each offering unique features and methodologies. Despite its computational nature, molecular docking has proven to be a valuable tool in drug discovery, enabling the rapid screening of large chemical libraries to identify potential drug candidates with high binding affinity and selectivity for the target protein.
Title : Fighting antibiotic resistance: Eliminating implant infections in humans without antibiotics
Thomas J Webster, Brown University, United States
Title : Novel polymer-mediated therapeutic options for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Turning problems into opportunities via small molecule design
Brian Blagg, University of Notre Dame, United States
Title : Durable surface-confined metal-terpyridine architectures for electrochromic applications
Olena Zenkina, Ontario Tech University, Canada
Title : Advances in plasma-based waste treatment
Hossam A Gabbar, Ontario Tech University, Canada
Title : Application of the Michaelis-Menten formalism to hydrocracking-related reactions and analysis of the features of the reactors
Orchidea Maria Lecian, Sapienza University of Rome, Italy